Clinical Trials
4 trialsNCT07380646 2026-04-30
the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT07528417 2026-04-22
MYELO-CAN:ABX
University of Manitoba
Phase 2 Not yet recruiting
NCT05537896 2026-04-16
Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia
West Virginia University
Phase 2 Recruiting
NCT05578326 2026-03-30
Study of Trilaciclib and Lurbinectidin
UNC Lineberger Comprehensive Cancer Center
Phase 2 Recruiting